STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns

STAT News

Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but shares of the company tanked on safety concerns. ...

전문 보기

관련 뉴스

관련 뉴스 제보는 로그인 후 가능합니다.

'science' 카테고리 뉴스

STAT의 다른 기사

STAT+: Online care is caught in the crossfire as states crack down on corporate medicine

STAT News

Opinion: The virtual end of the doctor’s office waiting room

STAT News

STAT+: Trump administration releases rules for new Medicaid work requirements

STAT News

STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns

관련 뉴스

'science' 카테고리 뉴스

Tropical Solstice Shadows

Genetic trade-off between youth and longevity uncovered

Medically tailored meals produce better health and lower costs, analysis finds

STAT의 다른 기사

STAT+: Online care is caught in the crossfire as states crack down on corporate medicine

Opinion: The virtual end of the doctor’s office waiting room

STAT+: Trump administration releases rules for new Medicaid work requirements